PP_1170x120_10-25-21

REYATAZ

Aurobindo launches atazanavir capsules

Aurobindo launches atazanavir capsules

EAST WINDSOR, N.J. — Aurobindo Pharma has launched atazanavir capsules 100 mg, 150 mg, 200 mg and 300 mg upon receiving final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application. Aurobindo’s Atazanavir capsules are an AB-rated generic equivalent to the reference listed drug REYATAZ. Atazanavir capsules are indicated for

Adheris Health